Teva intros generic Entocort EC

NORTH WALES, Penn. — Teva Pharmaceuticals on Thursday announced the introduction of its generic of Entocort EC (budesonide) enteric coated 3-mg capsules. The drug is indicated to treat mild to moderate active and in remission Crohn’s disease in the ileum and/or ascending colon. 

 

“Our customers count on Teva for a continuous supply of new generic products,” Teva SVP and general manager U.S. generics Maureen Cavanaugh said. “With the launch of budesonide capsules (enteric coated), we add another quality product to our broad line of affordable generic pharmaceuticals.”